FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer

Hematology / Oncology News Burst

Source: FDA Center for Drug Evaluation and Research - What's New - June 11, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news